HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Health (OTC Drugs)

Set Alert for Health (OTC Drugs)

Regulation/Legislation Explore this Topic

Set Alert for Regulation and Legislation {Health}

Latest From Regulation, Legislation & Health

US FDA Commissioner Hahn’s Star Turn: Baptism By Fire Turns Perilous

FDA Commissioner Stephen Hahn was added to the White House's pandemic task force as the outbreak grew, but he remained in a background role. That all changed the morning of 18 March, when President Trump tweeted: “I will be having a news conference today to discuss very important news from the FDA concerning the Chinese Virus!” A day later, Hahn was standing with Trump at the podium for the now-daily press briefings on Covid-19.

Coronavirus COVID-19 FDA

Spain Lists Certain OTCs As 'Essential' In Fight Against COVID-19

Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.

Spain Coronavirus COVID-19

In Pandemic Response, Quality Experts Advise Drug Manufacturers Move Products To Local Sites

AstraZeneca emptied its warehouses in January. “We said, OK let us pack everything and get it out in the door,” said Tony Mire-Sluis, head of global quality. The firm is allowing only crucial personnel in plants, or those responsible for running a plant or moving products; all others are working from home.

Coronavirus COVID-19 OTC Drugs

US Pandemic Relief Package Delivers OTC Industry Regulatory Wishes, Supplement Business Hopes

It’s unlikely any industry stakeholder or FDA official expected a bill providing emergency economic relief to consumers, industries and health care services and facilities in response to a pandemic, including extensive support opportunities for small businesses, would be the vehicle that delivers on both of the industry’s congressional wishes. The supplement industry also looks for help in CARES Act.

Coronavirus COVID-19 OTC Drugs

COVID-19 Prompts OTC Sales Restrictions Across Europe

Countries across Europe are restricting sales of OTC drugs in response to COVID-19 to maintain supply and counteract stockpiling. The approach varies widely across the region: countries such as Germany and France have introduced strict limits, while others, such as the UK and Ireland, have not ordered official restrictions. HBW Insight presents an analysis of the actions taken by 14 European countries to the upsurge in demand for OTCs.

Coronavirus COVID-19 Europe

OTC Monograph Reform Emerges In Senate Proposal For Covid-19 Economic Relief

Senate pandemic economic relief legislation legislation would reform monograph drug program and allow purchases of OTC drugs with pre-tax health savings accounts. But lingering disagreements between Democrats and Republicans blocked the Senate's passage of the bill on 25 March.

Coronavirus COVID-19 OTC Drugs
See All

Business Explore this Topic

Set Alert for Business {Health}

Latest From Deals & Health

Hypera Immediately Offloads Takeda Brands To Concentrate On Brazil

Hypera is offloading a basket of brands it recently acquired from Takeda which are sold primarily in Mexico to São Paulo-based Eurofarma. 

Mexico Deals

Stada Takes Lead In Russia's OTC Market As Group Sales Rise Double-Digits

Stada has taken the lead in the Russian OTC market and is implementing a turnaround plan in the country to take the business to the next level. 

Russian Federation Business Strategies

Podcast: How GSK's £1bn OTC Brand Sale Is Reshaping The Global Market

As GSK continues to sell off OTC assets in the wake of its merger with Pfizer, HBW Insight Editors Tom Gallen and David Ridley discuss how this torrent of M&A activity is shaking up the global consumer healthcare market. 

Market Intelligence Business Strategies
See All

Latest From Business Strategies & Health

In Pandemic Response, Quality Experts Advise Drug Manufacturers Move Products To Local Sites

AstraZeneca emptied its warehouses in January. “We said, OK let us pack everything and get it out in the door,” said Tony Mire-Sluis, head of global quality. The firm is allowing only crucial personnel in plants, or those responsible for running a plant or moving products; all others are working from home.

Coronavirus COVID-19 OTC Drugs

Light At End of Tunnel As Some Conferences Reschedule, But Lights Off For Others In 2020

CHPA’s Regulatory, Scientific & Quality Conference rescheduled for 1-2 September and the Dietary Supplements Regulatory Summit for 16 September. Several spring conferences canceled due to Covid-19 will not be rescheduled, groups say.

Coronavirus COVID-19 Dietary Supplements

OTC Monograph Reform Emerges In Senate Proposal For Covid-19 Economic Relief

Senate pandemic economic relief legislation legislation would reform monograph drug program and allow purchases of OTC drugs with pre-tax health savings accounts. But lingering disagreements between Democrats and Republicans blocked the Senate's passage of the bill on 25 March.

Coronavirus COVID-19 OTC Drugs
See All

Latest From Sales & Earnings & Health

Recordati’s OTC Sales Lifted by Acquisitions And Italy

Italy's Recordati enjoyed strong growth in its home market and abroad, lifting OTC group sales in 2019.

Sales & Earnings Italy

RB To Split OTC And Infant Nutrition As CEO Hits Reset Button

Reckitt Benckiser's new CEO Laxman Narasimhan has unveiled a turnaround plan which will see the company's OTC drugs and dietary supplements housed in a separate business to its infant nutrition products. RB is investing £2bn to get back on track after a couple of difficult years.

Business Strategies Sales & Earnings

Perrigo's Infant Formula Already A Key Sales Driver, And Nutrition Sector Takes Larger Role Ahead

OTC private label giant said gaining another grocery chain as an infant formula customer was a key sales driver in the 2019 Q4, with nutrition sales up 21% to account for 17% of Americas consumer health sales growth. The firm plans to re-enter the broader VMS space, but infant formula helped its global consumer health net sales reach $1.1bn in the October-December period.

Sales & Earnings OTC Drugs
See All

Latest From Legal Issues & Health

Purell Battling Class Actions Over Disease Claims While World Scrambles To Increase Hand Sanitizer Supplies

Leading chemical firms, beauty and consumer health companies, even distilleries and medical marijuana cultivators are adapting operations to meet global demand for hand sanitizers amid the COVID-19 pandemic. Meanwhile, plaintiff’s attorneys are busy with multiple class actions against Purell manufacturer GOJO Industries for alleged false advertising following a January warning letter to the firm from the US FDA.

United States Legal Issues

OTC Device Claims Regulation: FTC Targets Quell On Pain Relief, FDA Warns Zona Plus On BP

An FTC member doubts NeuroMetrix crossed all FDA regulatory lines in advertising for Quell wearable pain relief technology that attorneys alleged. FDA warning letter says Zona Health executives said they “would ‘remain in all regulatory guidelines’" when the agency in 2018 explained claims violations.

OTC Devices Enforcement

Bayer Consumer Health Recovery Rides Allergy, Dermatology Brand Sales

Q4 sales in OTC allergy/cold segment, which includes the Claritin allergy and Afrin nasal congestion lines, grew 5% adjusted while dermatology sector with Bepanthen and Canesten skin care brands grew 3.8%. Adjusted for the impact of foreign exchange and portfolio changes, thouhg, consumer unit’s full-year sales were flat.

OTC Drugs Sales & Earnings
See All

Marketing Explore this Topic

Set Alert for Marketing {Health}

Latest From Launches & Health

TheOTCLab Launches World’s First Fungal Nail Plaster

Dutch foot-care specialists TheOTCLab launches what it claims to be the world's first fungal nail plaster. 

Health OTC Drugs

Health And Wellness Trademark Review 24 March, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Trademarks OTC Drugs

Dermatonics Kicking Open The UK’s Foot-Care Category

HBW Insight speaks to Dermatonics director Greg Ansell about how his company is using naturals and female-friendly packaging to break open the UK's crowded OTC foot-care category. 

Health OTC Drugs
See All

Latest From Ad Campaigns & Health

Sanofi Tapping AI To Help Consumers Manage IBS

Sanofi is utilizing AI technology to help UK consumers to better manage their IBS and digestive symptoms. 

Artificial Intelligence Digital Health

John Smith Recognized For His Outstanding Contribution To The OTC Industry

PAGB chief executive John Smith was honored at the OTC Marketing Awards 2020 for the outstanding contribution he has made to the consumer healthcare industry.

Leadership OTC Drugs

Perrigo Crowned Company of the Year and Pfizer’s Viagra Is Best Brand At OTC Marketing Awards 2020

Perrigo was the night's biggest winner at the OTC Marketing Awards 2020, with Teva and The Mentholatum Company also among the firms recognized for outstanding consumer healthcare campaigns.

Ad Campaigns Launches
See All

Latest From Ad Complaints & Health

UK Industry Welcomes Coronavirus Responsible Advertising Guidelines

UK industry association, PAGB, welcomes a clarification from the country's advertising standards authority on how consumer healthcare products should be advertised during the Covid-19 pandemic.

Health OTC Drugs

OTC Device Claims Regulation: FTC Targets Quell On Pain Relief, FDA Warns Zona Plus On BP

An FTC member doubts NeuroMetrix crossed all FDA regulatory lines in advertising for Quell wearable pain relief technology that attorneys alleged. FDA warning letter says Zona Health executives said they “would ‘remain in all regulatory guidelines’" when the agency in 2018 explained claims violations.

OTC Devices Enforcement

OTC Incontinence Device Ad Claims Sunk In UK, But US Label Claims Have FDA OK

UK ASA upholds complaints that questioned claims made in 2018 TV ads that Innovo was clinically proven to strengthen the pelvic floor and treat bladder weakness. In the US, however, claims Atlantic Therapeutics will use to promote OTC sales of Innovo were approved by FDA.

OTC Devices Ad Complaints
See All
UsernamePublicRestriction

Register